Bookmark and Share

News & Events

Department of Radiation Oncology Launches Program of Excellence in Technology Translational Research

Monday, September 17, 2007

cutting.jpg
 Dr. William Regine watches as Roslyn and Len Stoler cut the ribbon to open the Department of Radiation Oncology's new research center.
 

Radiation oncology specialists at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have launched a Program of Excellence to promote technological research they hope will lead to more precise and effective radiation therapies and better outcomes for cancer patients. A reception was held Sept. 14, 2007, at the University of Maryland Medical Center to kick off the Department of Radiation Oncology’s Program of Excellence in Technology Translational Research and unveil the new research center.

Mohan Suntha, M.D., professor and vice chairman of the Department of Radiation Oncology at the University of Maryland School of Medicine and associate director of clinical affairs for the Greenebaum Cancer Center, said, "This is a unique opportunity for our department to be at the forefront of developing new technologies to make radiation therapy more precise and targeted, resulting in more effective treatments, fewer side effects and higher cure rates for patients. The focus of our research is always on improving patient care."

One of the ways they hope to do that is with state-of-the-art equipment, including the new Trilogy linear accelerator made by Varian Medical Systems, Inc., which will be used solely for research. This powerful image-guided radiation therapy system delivers high-dose radiation to even the smallest tumors and can target an area as small as a pencil point. "Through ongoing collaborations between the researchers at Maryland and Varian, under our existing research relationship, we will continue to improve the future of patient care and endeavor to defeat our common foe – cancer," said Dow Wilson, president of Varian’s Oncology Systems business.

Roslyn and Len Stoler, whose generous donations helped fund the Program for Excellence, cut the ribbon to the new research center. Stoler is founder and president of the Len Stoler Automotive Group. The Stolers are major supporters of the University of Maryland Marlene and Stewart Greenebaum Cancer Center, having already donated $5 million for a state-of-the-art outpatient facility that opened in 2005. 

Yet as Mr. Stoler and his wife toured the new center and got a detailed explanation of the linear accelerator's capabilities from William Regine, MD, professor and chair of the Department of Radiation Oncology, the smile on his face made it very clear that he considers all he gives as money well spent.

Contact

Karen Warmkessel
Media Relations
410-328-8919
kwarmkessel@umm.edu

Contact Media Relations
Phone: (410) 328-8919

Search Articles

Learn More


trilogy175.jpg
 The Varian Trilogy linear accelerator delivers high-dose radiation to even the smallest tumors.
 
plaque.jpg
 The Stolers will be forever recognized for their generosity with a sign on the wall outside the room that houses the linear accelerator.
 




stoler_docs.jpg
 Dean E. Albert Reece, MD, PhD, MBA; Robert Barish, MD; William Regine, MD and Len Stoler watch in interest as the linear accelerator's capabilities are demonstrated.